Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2026 (TTM): S$0.06667

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is S$0.06466. In 2025 the company made an earnings per share (EPS) of S$0.04433 a decrease over its 2024 EPS that were of S$0.05843.

EPS history for Shanghai RAAS Blood Products from 2005 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	S$0.06667	50.42%
2025	S$0.04433	-24.13%
2024	S$0.05843	18.38%
2023	S$0.04935	-5.91%
2022	S$0.05246	36.15%
2021	S$0.03853	-7.39%
2020	S$0.04160	87.44%
2019	S$0.02220	-138.11%
2018	S-$0.05824	-272.5%
2017	S$0.03376	-45.02%
2016	S$0.06141	5.85%
2015	S$0.05801	127.47%
2014	S$0.02550	48.29%
2013	S$0.01720	29.9%
2012	S$0.01324	13.1%
2011	S$0.01171	14.18%
2010	S$0.01025	40.49%
2009	S$0.007298	13.05%
2008	S$0.006456	18.08%
2007	S$0.005467	-37.8%
2006	S$0.008790	2.48%
2005	S$0.008577

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)